申请人:Recherche Syntex
公开号:US04810706A1
公开(公告)日:1989-03-07
New compounds of formulas I and II ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein M is selected from the group consisting of hydrogen, morpholino, benzylamino, di-n-lower alkylamino, n-lower alkylamino and ##STR2## wherein Ar is optionally substituted phenyl; Z.sub.1 and Z.sub.2 are each independently selected from the group consisting of CH.sub.2, CHOB and C.dbd.O, wherein B is selected from the group consisting of hydrogen and alkanoyl; Y is oxygen or nothing; n is an integer from 0-4 but cannot be zero when Z.sub.1 is CHOB; m is an integer from 0-4 but cannot be zero when Z.sub.2 is CHOB; R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy; R.sub.4 is lower alkyl; and R.sub.5 is hydrogen or lower alkyl, are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold. They are also vasodilators.
公式I和II的新化合物及其药物可接受的酸盐,其中M选自氢,吗啡基,苄基氨基,二取代烷基氨基,烷基氨基和其中Ar是可选择的取代苯基; Z1和Z2各自独立地选自CH2,CHOB和C = O的群,其中B选自氢和烷酰基; Y是氧或无; n是0-4的整数,但当Z1为CHOB时不能为零; m是0-4的整数,但当Z2为CHOB时不能为零; R1,R2和R3各自独立地为氢,卤素,羟基,三氟甲基,烷基或烷氧基; R4为低烷基; R5为氢或低烷基。它们是抗组胺剂,因此在呼吸系统疾病,包括哮喘,花粉热,过敏和感冒的治疗中非常有用。它们也是血管扩张剂。